Literature DB >> 29802079

Mortality from Parkinson's disease in China: Findings from a ten-year follow up study in Shanghai.

Yueqi Zhang1, Chunfang Wang2, Ying Wang1, Qin Xiao1, Jun Liu1, Jianfang Ma1, Haiyan Zhou1, Jing Pan1, Yuyan Tan1, Shengdi Chen1, Gang Xu3, Gang Wang4.   

Abstract

BACKGROUND: Standardized mortality ratio (SMR) is the most frequently used index in Parkinson's disease (PD) survival survey. However, there is little SMR data in PD from China.
OBJECTIVE: To examine the outcome, including overall and cause-specific mortality, of PD patients subsequent to 10 years of surveillance in Shanghai, China. This is an extension study of our previous investigation on mortality.

METHODS: One hundred fifty-seven PD patients recruited from the movement disorder clinic of Rui Jin Hospital in 2006 were followed up until December 31, 2016 or death, representing a follow-up period of up to 10 years. Overall and cause-specific standardized mortality ratios (SMR) were calculated, and predictors for survival at disease onset were estimated.

RESULTS: Thirty one patients had died by December 31, 2016, and the SMR at 10 years of follow-up was 0.87 (0.59-1.25). The primary direct cause of death was respiratory disease (SMR = 3.52, 95% CI 1.98-5.78). Employing Cox's proportional hazard modeling, postural instability gait disorder (PIGD) type and older age at onset predicted poor survival in this cohort.
CONCLUSIONS: This finding confirms the similar survival of patients with PD to the control population in the post-levodopa era. PIGD type and older age at onset had a negative impact on survival.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Mortality; Parkinson's disease; Standardized mortality ratio

Mesh:

Year:  2018        PMID: 29802079     DOI: 10.1016/j.parkreldis.2018.05.012

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

1.  Lower Blood Lipid Level Is Associated with the Occurrence of Parkinson's Disease: A Meta-Analysis and Systematic Review.

Authors:  Xue Hong; Wenting Guo; Shanshan Li
Journal:  Int J Clin Pract       Date:  2022-06-09       Impact factor: 3.149

Review 2.  Ethnic Variation in the Manifestation of Parkinson's Disease: A Narrative Review.

Authors:  Aaron Ben-Joseph; Charles R Marshall; Andrew J Lees; Alastair J Noyce
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

Review 3.  Challenges and Perspectives in the Management of Late-Stage Parkinson's Disease.

Authors:  Margherita Fabbri; Linda Azevedo Kauppila; Joaquim J Ferreira; Olivier Rascol
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

Review 4.  Sudden unexpected death in Parkinson's disease: Insights from clinical practice.

Authors:  Fulvio A Scorza; Marcia Guimarães-Marques; Mariana Nejm; Antônio Carlos G de Almeida; Carla A Scorza; Ana C Fiorini; Josef Finsterer
Journal:  Clinics (Sao Paulo)       Date:  2022-02-10       Impact factor: 2.365

5.  Effects of physician visit frequency for Parkinson's disease treatment on mortality, hospitalization, and costs: a retrospective cohort study.

Authors:  Takako Fujita; Akira Babazono; Sung-A Kim; Aziz Jamal; Yunfei Li
Journal:  BMC Geriatr       Date:  2021-12-15       Impact factor: 3.921

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.